Review
Impact of Chronic Kidney Insufficiency on Cardiovascular Outcomes in Patients that Undergo Coronary Revascularization: A Historical Review
Koh Choong Hou,1 Kenny Sin Yoong Kong,2 Terence Kee Yi Shern,3 Jack Tan Wei Chieh1
- Summary
- Supplementary Material
- References
- About this Article
Abstract
Chronic kidney disease (CKD) is associated with poorer short and long-term cardiovascular morbidity and mortality. Even after the commencement of haemodialysis in end stage renal failure patients, mortality exceeds 20% in the first year1. More than 50% of these deaths are contributed by cardiovascular diseases (CVD), of which 20% are caused by acute myocardial infarction2. Consequent to these findings, the degree and impact of coronary revascularization on CKD patients represents a clinical challenge, especially in the setting of advanced stages of CKD.
KeywordsChronic Kidney Disease - Percutaneous Coronary Intervention - Chronic Kidney Disease Patient - Ticagrelor - Bare Metal Stents
1 National Heart Centre Singapore, Department of Cardiovascular Medicine. 5 Hospital Drive, Singapore 169609
2 National Heart Centre Singapore, Department of Cardiothoracic Surgery. 5 Hospital Drive, Singapore 169609
3 Singapore General Hospital, Department of Renal Medicine. Outram Road, Singapore 169608
© The Author(s) 2016. This article is published with open access by ASEAN Federation of Cardiology.
Correspondence: Koh Choong Hou, Department of Cardiology, National Heart Center Singapore. Email: koh.choong.hou@nhcs.com.sg
Open Access: This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
Supplementary Material
Nil
References
1. Wolfe RA, Port FK et al. Excerpts from the United States Renal Data System, 1998 annual data report: V. Patient mortality and survival. Am J Kidney Dis 1998; 32 Suppl 1: S69-80. CrossRef
2. National Institute of Diabetes and Digestive and Kidney Diseases. Renal Data System. USRDS 2000 Annual Data Report. NIH Publication no. 00-3176, 583-689, 2000. Bethesda MA.
3. Nakano T et al. Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama Study. AM J Kidney Dis 2010;55:21-30. CrossRef PubMed
4. Chonchol M et al. Chronic kidney disease is associated with angiographic coronary artery disease. Am J Nephrol 2008; 28:354-360. CrossRef PubMed
5. Ix JH et al. Association between renal insufficiency and inducible ischaemia in patients with coronary artery disease: the Heart and Soul Study. J Am Soc Nephrol 2003; 14:v3233- 323-8.CrossRef
6. Joki N et al. Onset of coronary artery disease prior to initiation of haemodialysis in patients with end stage renal disease. Nephro Dial Transplant 1997; v12: 718-723. CrossRef
7. Ohtake T et al. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J Am Soc Nephrol 2005; 16: 1141-48. CrossRef PubMed
8 .Weiner DE et al. The Framingham predictive instrument in chronic kidney disease. J AM Coll Cardio 2007; 50: 217-224. CrossRef
9. Longenecker JC et al. Traditional cardiovascular risk factors in dialysis patients compared with the general population: the CHOICE study. J Am Soc Nephrol 2002; 13:1918-27. CrossRef PubMed
10. deFillipi C et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term haemodialysis. JAMA 2003; 290: 353-359. CrossRef
11. Giovanunucci E et al. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Inern Med 2008; 168: 1174-80.
12. Gutierrez OM et al. Fibroblast growth factor 23 and mortality among patients undergoing haemodialysis. N Engl J Med 2008; 359: 584-592. CrossRef PubMed PubMedCentral
13. Herzog CA et al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes. Kidney International 2011.
14. Sarnak MJ et al. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease. Circulation 2003; 108: 2154-2169. CrossRef PubMed
15. Powell KL, Smith JM, Woods SE, Hendy MP, Engel AM, Hiratzka LF. Coronary artery bypass grafting in patients with dialysis-dependent end stage renal disease: a prospective, nested casecontrol study. J Card Surg 2004; 19(5): 449-52. CrossRef PubMed
16. Beckermann J, Van Camp J, Li S, Wahl SK, Collins A, Herzog CA. On-pump versus off-pump coronary surgery out- comes in patients requiring dialysis: perspectives from a single center and the United States experience. J Thorac Cardiovasc Surg 2006; 131(6): 1261-6. CrossRef
17. Tabata M, Takanashi S, Fukui T, Horai T, Uchimuro T, Kitabayashi K, Hosoda Y. Off-pump coronary artery bypass grafting in patients with renal dysfunction. Ann Thorac Surg 2004; 78(6): 2044-9. CrossRef PubMed
18. Dewey TM, Herbert MA, Prince SL, Robbins CL, Worley CM, Magee MJ, Mack MJ. Does coronary artery bypass graft surgery improve survival among patients with end-stage renal disease? Ann Thorac Surg 2006; 81(2): 591-8.
19. Ariyoshi T, Eishi K, Yamachika S, Hazama S, Takai H, Odate T, Matsukuma S. Perioperative and mid-term results of coronary bypass surgery in patients undergoing chronic dialysis. Ann Thorac Cardiovasc Surg 2006; 12(4): 257-64. PubMed
20. Papadimitriou LJ, Marathias KP, Alivizatos PA, Michalis A, Palatianos GM, Stavridis GT, et al. Safety and efficacy of offpump coronary artery bypass grafting in chronic dialysis patients. Artif Organs 2003; 27(2): 174-80. CrossRef PubMed
21. Hirose H, Amano A, Takahashi A. Efficacy of off-pump coronary artery bypass grafting for the patients on chronic hemodialysis. Jpn J Thorac Cardiovasc Surg 2001; 49(12): 693-9. CrossRef PubMed
22. Ashrith et al. Revascularization options in patients with chronic kidney disease. Texas Heart Inst J 2010; 37(1): 9-18.
23. Magdalena Polanska-Skrzypczyk et al. Prognostic value of renal function in STEMI patients treated with primary PCI: ANIN Registry. Br J Cardio 2013; 20: 6-5.
24. Sadeghi et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 2003; 108: 2769-2775. CrossRef PubMed
25. Rubenstein et al. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation 2000; 102: 2966-72. CrossRef PubMed
26. Best PJM et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardio 2002; 39: 1113-9. CrossRef
27. Ki Young Na et al. The association between kidney function, coronary artery disease, and clinical outcome in patients undergoing coronary angiography. J Korea Med Sci 2009; 24(Suppl 1):S87-94.
28. Hassani SE et al. Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients. J Invasive Cardiol 2006; 18(6): 273-7. PubMed
29. Latif et al. In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents. JACC Cardiovasc Intv 2009(2); 37-45.
30. Barthelemy et al. One year clinical outcomes in patients with chornic renal failure treated by percutaneous coronary intervention with drug-eluting stent. Arch Cardiovasc Dis 2011; 104: 604-610. CrossRef PubMed
31. Aoki J et al. Five year clinical effect of coronary stenting and coronary artery bypass grafting in renal insufficient patients with multivessel coronary artery disease: insights from ARTS trial. Eur Heart J 2005; 26: 1488-1493. CrossRef PubMed
32. Herzog CA. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 2002; 106: 2207-2211. CrossRef PubMed
33. Rinehart AL, Herzog CA, Collins AJ, Flack JM, Ma JZ, Opsahl JA. A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis 1995; 25: 281-290. CrossRef PubMed
34. Marso SP, Gimple LW, Philbrick JT, DiMarco JP. Effectiveness of percutaneous coronary interventions to prevent recurrent coronary events in patients on chronic hemodialysis. Am J Cardiol 1998; 82: 378-380. CrossRef PubMed
35. Hemmelgarn et al. Survival after coronary revascularization among patients with kidney disease. Circulation 2004; 110: 1890-95. CrossRef PubMed
36. Charytan DM, Herzog A et al. Risks of death and end stage renal disease after surgical compared with percutaneous coronary revascularization in elderly patients with chronic kidney disease. Circulation 2012; 126[suppl 1]:S164-S169. CrossRef PubMed PubMedCentral
37. William Chan et al. Clinical outcomes of treatment by percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with chronic kidney disease undergoing index revascularization in Ontario. Circ Cardiovasc Interv 2015; 8:e001973. CrossRef PubMed
About this Article
TitleImpact of Chronic Kidney Insufficiency on Cardiovascular Outcomes in Patients that Undergo Coronary Revascularization: A Historical Review
Open Access
Available under Open Access
Journal
>> ASEAN Heart Journal
>> 24:1
Online Date
21 November 2019
DOI
10.7603/s40602-016-0008-1
Online ISSN
2315-4551
Publisher
ASEAN Federation of Cardiology
Additional Links
Topics
Cardiology
Keywords
Chronic Kidney Disease
Percutaneous Coronary Intervention
Chronic Kidney Disease Patient
Ticagrelor
Bare Metal Stents
Author Affiliations
1. Department of Cardiovascular Medicine, National Heart Centre Singapore, 5 Hospital Drive, Singapore, Singapore, 169609
2. Department of Cardiothoracic Surgery, National Heart Centre Singapore, 5 Hospital Drive, Singapore, Singapore, 169609
3. Department of Renal Medicine, Singapore General Hospital, Outram Road, Singapore, Singapore, 169608
Correspondence to Koh Choong Hou, koh.choong.hou@nhcs.com.sg